{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T06:51:27Z","timestamp":1679295087071},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Optometry - Journal of the American Optometric Association"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.optm.2006.02.001","type":"journal-article","created":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T12:13:28Z","timestamp":1143634408000},"page":"177-179","source":"Crossref","is-referenced-by-count":8,"title":["Decreased high-density lipoprotein serum levels associated with topical bimatoprost therapy"],"prefix":"10.1016","volume":"77","author":[{"given":"Shannon L.","family":"Steinh\u00e4user","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.optm.2006.02.001_bib1","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.ophtha.2004.02.006","article-title":"Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma","volume":"111","author":"Christiansen","year":"2004","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.optm.2006.02.001_bib2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajo.2004.03.006","article-title":"Conjunctival hyperemia associated with bimatoprost use","volume":"138","author":"Leal","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.optm.2006.02.001_bib3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/01.opx.0000141791.16683.4a","article-title":"Deepening of lid sulcus from topical bimatoprost therapy","volume":"81","author":"Peplinski","year":"2004","journal-title":"Optom Vis Sci"},{"issue":"5","key":"10.1016\/j.optm.2006.02.001_bib4","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ajo.2003.11.068","article-title":"Cystoid macular edema in a low-risk patient after switching from latanoprost to bimatoprost","volume":"137","author":"Carrillo","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.optm.2006.02.001_bib5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1468-3083.2004.01020.x","article-title":"Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost","volume":"18","author":"Chen","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.optm.2006.02.001_bib6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ajo.2003.11.020","article-title":"Topical prostaglandin F(2alpha) analog induced poliosis","volume":"137","author":"Herane","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.optm.2006.02.001_bib7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ajo.2003.09.002","article-title":"Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost","volume":"137","author":"Hart","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.optm.2006.02.001_bib8","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/S0886-3350(03)00470-X","article-title":"Bilateral nongranulomatous anterior uveitis associated with bimatoprost","volume":"29","author":"Packer","year":"2003","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"10.1016\/j.optm.2006.02.001_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00061198-200312000-00006","article-title":"Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects","volume":"12","author":"Stewart","year":"2003","journal-title":"J Glaucoma"},{"issue":"4","key":"10.1016\/j.optm.2006.02.001_bib10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ajo.2003.11.073","article-title":"Increased periocular pigmentation with ocular hypotensive lipid use in African Americans","volume":"137","author":"Herndon","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.optm.2006.02.001_bib11","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/S0039-6257(02)00292-8","article-title":"Mechanism and clinical significance of prostaglandin-induced iris pigmentation","volume":"47","author":"Stjernschantz","year":"2002","journal-title":"Surv Ophthalmol"},{"issue":"19","key":"10.1016\/j.optm.2006.02.001_bib12","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.optm.2006.02.001_bib13","unstructured":"American Heart Association. http:\/\/www.americanheart.org\/presenter.jhtml?identifier=183 . Last accessed September 15, 2004."},{"issue":"2","key":"10.1016\/j.optm.2006.02.001_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1527-3466.2004.tb00134.x","article-title":"Bimatoprost","volume":"22","author":"Woodward","year":"2004","journal-title":"Cardiovasc Drug Rev"},{"issue":"1","key":"10.1016\/j.optm.2006.02.001_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0885-4505(86)90114-3","article-title":"Influence of prostaglandin E1 on high density lipoprotein-fraction lipid levels in rats","volume":"36","author":"Dionyssiou-Asteriou","year":"1986","journal-title":"Biochem Med Metab Biol"},{"issue":"4","key":"10.1016\/j.optm.2006.02.001_bib16","first-page":"643","article-title":"Effect of prostaglandins on lipid transfer between high- and low-density lipoproteins in human plasma","volume":"53","author":"Muzia","year":"1988","journal-title":"Biokhimiia"},{"issue":"1","key":"10.1016\/j.optm.2006.02.001_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0885-4505(90)90039-4","article-title":"Changes in serum lipids in rats treated with PGF2 alpha","volume":"44","author":"Dionyssiou-Asteriou","year":"1990","journal-title":"Biochem Med Metab Biol"},{"key":"10.1016\/j.optm.2006.02.001_bib18","unstructured":"Lumigan package insert. Allergan, Inc. Irvine, California, August 2002."},{"issue":"3","key":"10.1016\/j.optm.2006.02.001_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0039-6257(98)00030-7","article-title":"Serum lipid physiology and the influence of glaucoma medications","volume":"43","author":"Stewart","year":"1998","journal-title":"Surv Ophthalmol"}],"container-title":["Optometry - Journal of the American Optometric Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183906001175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183906001175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T13:00:14Z","timestamp":1547730014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529183906001175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1529183906001175"],"URL":"https:\/\/doi.org\/10.1016\/j.optm.2006.02.001","relation":{},"ISSN":["1529-1839"],"issn-type":[{"value":"1529-1839","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}